Mirabegron
Mirabegron is an active ingredient in 21 FDA-listed drug products sold under 3 names.
Drugs containing Mirabegron
Products and strengths
| NDC | Product | Strength | Labeler |
|---|---|---|---|
| 69238-2860 | Mirabegron Tablet, Film Coated, Extended Release | 25 mg/1 | Amneal Pharmaceuticals NY LLC |
| 69238-2861 | Mirabegron Tablet, Film Coated, Extended Release | 50 mg/1 | Amneal Pharmaceuticals NY LLC |
| 67877-890 | Mirabegron For Suspension, Extended Release | 8 mg/mL | Ascend Laboratories, LLC |
| 71335-2807 | Mirabegron Tablet, Film Coated, Extended Release | 25 mg/1 | Bryant Ranch Prepack |
| 71335-2809 | Mirabegron Tablet, Film Coated, Extended Release | 25 mg/1 | Bryant Ranch Prepack |
| 71335-2810 | Mirabegron Tablet, Film Coated, Extended Release | 50 mg/1 | Bryant Ranch Prepack |
| 71335-2808 | Mirabegron Tablet, Film Coated, Extended Release | 50 mg/1 | Bryant Ranch Prepack |
| 68180-152 | Mirabegron Tablet, Film Coated, Extended Release | 50 mg/1 | Lupin Pharmaceuticals, Inc. |
| 68180-151 | Mirabegron Tablet, Film Coated, Extended Release | 25 mg/1 | Lupin Pharmaceuticals, Inc. |
| 67184-0571 | Mirabegron Tablet, Film Coated, Extended Release | 25 mg/1 | Qilu Pharmaceutical Co., Ltd. |
| 70518-4304 | Mirabegron Tablet, Extended Release | 50 mg/1 | REMEDYREPACK INC. |
| 70518-4665 | Mirabegron Tablet, Film Coated, Extended Release | 50 mg/1 | REMEDYREPACK INC. |
| 70518-4631 | Mirabegron Tablet, Extended Release | 25 mg/1 | REMEDYREPACK INC. |
| 70771-1752 | Mirabegron Tablet, Extended Release | 25 mg/1 | Zydus Lifesciences Limited |
| 70771-1753 | Mirabegron Tablet, Extended Release | 50 mg/1 | Zydus Lifesciences Limited |
| 70710-1159 | Mirabegron Tablet, Extended Release | 25 mg/1 | Zydus Pharmaceuticals (USA) Inc. |
| 70710-1160 | Mirabegron Tablet, Extended Release | 50 mg/1 | Zydus Pharmaceuticals (USA) Inc. |
| 67184-0572 | Mirabgeorn Tablet, Film Coated, Extended Release | 50 mg/1 | Qilu Pharmaceutical Co., Ltd. |
| 0469-2601 | Myrbetriq Tablet, Film Coated, Extended Release | 25 mg/1 | Astellas Pharma US, Inc. |
| 0469-5020 | Myrbetriq Granule, For Suspension, Extended Release | 8 mg/mL | Astellas Pharma US, Inc. |
| 0469-2602 | Myrbetriq Tablet, Film Coated, Extended Release | 50 mg/1 | Astellas Pharma US, Inc. |